SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-130893
Filing Date
2011-05-06
Accepted
2011-05-06 16:53:35
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 581911
2 SEVENTH AMENDMENT dex101.htm EX-10.1 8746
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6665
4 CERTIFICATION OF VICE PRESIDENT FINANCE AND CHIEF ACCOUNTING OFFICER dex312.htm EX-31.2 6773
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3691
6 CERTIFICATION OF VICE PRESIDENT FINANCE AND CHIEF ACCOUNTING OFFICER dex322.htm EX-32.2 3618
  Complete submission text file 0001193125-11-130893.txt   612397
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34828 | Film No.: 11820356
SIC: 2834 Pharmaceutical Preparations